Fetzima, a medication used to treat major depressive disorder, is available with a titration pack to help patients gradually adjust to the dosage [1]. This pack is designed to facilitate a slow increase in medication strength, potentially reducing side effects [1].
How does the Fetzima titration pack work?
The Fetzima titration pack contains multiple blister cards with doses that increase over time. This allows patients to start with a lower dose and progressively move to higher doses as prescribed by their healthcare provider. For example, a typical titration schedule might involve starting at 20 mg for a week, then moving to 40 mg for a week, and eventually reaching the target dose of 60 mg or 80 mg [1].
Where can I find a Fetzima coupon or savings card?
Savings cards or coupons for Fetzima may be available through the drug manufacturer's website or through various pharmaceutical savings program websites. These can help reduce the out-of-pocket cost for eligible patients. Patients are advised to check the official Fetzima website or consult their pharmacist for current savings program information [2].
What is the difference between Fetzima and other antidepressants?
Fetzima (levomilnacipran) is a serotonin-norepinephrine reuptake inhibitor (SNRI) [1]. Unlike some other antidepressants, it is believed to have a more balanced inhibition of norepinephrine and serotonin reuptake. This mechanism of action may contribute to its effectiveness in treating major depressive disorder [3].
When does Fetzima's patent expire?
Information regarding Fetzima's patent expiration can be found through specialized patent tracking services. For instance, DrugPatentWatch.com provides detailed information on drug patents and their expiry dates [4]. Examining these resources can reveal when the drug may face generic competition.
What are the potential side effects of Fetzima?
Common side effects reported with Fetzima include nausea, constipation, increased heart rate, sweating, and difficulty urinating [1]. Patients should discuss any concerns about side effects with their doctor, who can advise on managing them or adjusting the dosage.
Sources:
[1] Fetzima - Drug Information
[2] Fetzima Savings Card
[3] Levomilnacipran: An Update on its Use in the Management of Major Depressive Disorder
[4] DrugPatentWatch.com